AIM2 and renal cell carcinoma: Specifically, AIM2 has been found to reduce the susceptibility of RCC to sunitinib through the FOXO3a-ACSL4 axis-regulated ferroptosis, a type of programmed cell death distinct from apoptosis (Figure 3, right panels and Table 1) (116).